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Methods: Translatability assessments of the US English version of the IBS-D 
PRO were performed by experienced PRO translators who were native speakers 
of each target language and currently residing in-country. Languages included: 
Chinese (China); Dutch (Netherlands); French (Belgium); German (Germany); 
Japanese (Japan); Polish (Poland); Portuguese (Brazil); Russian (Russia); Spanish 
(Mexico); and Spanish (US). The project team assessed the instrument to identify 
potential linguistic and/or cultural adaptation issues. After the identified issues 
were resolved, the instrument was translated into Spanish (US) and Japanese 
through a process of two forward translations, one reconciled translation, and 
one back translation. The project team reviewed the translated versions before 
the instruments were evaluated by cognitive debriefing interviews (CDIs) with 
samples of five Spanish (US) and five Japanese IBS-D patients. Results: A few 
linguistic and cultural adaptation concerns were identified during the translat-
ability assessment as requiring minor revisions: mainly the presentation of dates/
times and word structure. During the CDIs, two out of five Spanish respondents 
misunderstood the term “bowel movement” to mean only diarrhea in the Spanish 
version. Consequently, the term was changed from “movimiento intestinal” to 
“evacuaciones.” None of the Japanese respondents identified issues with the 
Japanese version. ConClusions: The translatability of the IBS-D PRO instru-
ment into ten target languages was confirmed, with only minor changes made to 
the translations of the instrument. The translation and linguistic validation into 
Spanish (US) and Japanese provide evidence that this instrument can be used in 
multinational trials and clinical settings.
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objeCtives: The haemorrhoidal disease is a frequent and chronic illness. The 
anal fissure is the second reason of proctologic medical visits. At the moment, 
there is only a clinical score measuring the grade of the haemorrhoids, but the 
impact of the disease on the patients’ quality of life is not evaluated. The objec-
tive of this study is to validate a specific questionnaire to evaluate the burden 
of the haemorrhoidal disease and anal fissure (HEMO-FISS) on the patients’ daily 
life. Methods: The questionnaire HEMO-FISS, including 38 questions, has been 
submitted to patients suffering from a haemorrhoidal disease or an anal fissure and, 
consulting a participating proctologist in France during the study period (2012-2014). 
The psychometric properties were evaluated by testing the acceptability, construct 
validity and reliability. A principal component analysis (PCA) using Varimax rota-
tion, a Spearman correlation coefficient with SF-12 and PGWBI and a multi-trait 
analysis (MTA) were conducted to assess the construct validity of the questionnaire. 
The reliability was evaluated using Cronbach’s alpha coefficient (CAC). Backward 
Cronbach alpha curves (BCAC) were drawn. Results: A total of 256 patients were 
included in the study. Following the factor analysis, four dimensions were defined: 
physical disorders, psychology, troubles defecating and sexuality. The number of 
questions was reduced from 38 to 28. Item reduction was based on MTA and BCAC. 
A strong correlation was observed between SF-12 and the dimensions regarding 
physical disorders (with PCS) and psychology (with MCS). The Cronbach’s coef-
ficient (all > 0.7) reflected a good internal consistency of the different dimensions 
of the questionnaire. ConClusions: The questionnaire HEMO-FISS displays good 
properties to evaluate the burden of haemorrhoids and anal fissures. Consecutive 
to this preliminary validation, a graded response model (GRM) will be developed to 
precise the unidimensionality of each dimensions.
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objeCtives: The study focused on a secondary aspect of liver diseases, never 
investigated in Italy so far. The study purpose was in fact to obtain the patients’ 
perception about the role of nutrition during the disease phases and in general for 
liver welfare, with the final aim of understanding the importance given to nutri-
tion by patients and the current disinformation to be possibly tackled. Methods: 
EpaC is the most important Italian NGO for hepatopathic patients. An anonymous 
web-based questionnaire was published on the association website www.epac.it. 
It was composed of multiple choice and open questions investigating the gen-
eral info of the patient, health state, and opinions/perceptions about nutritional 
aspects. Results: 483 patients participated the survey. The profile of participants 
was assessed concerning sex, age, health condition, presence of cirrhosis. Mean age 
was 52.9 (min 24 – max 80), 60% males, 76% HCV-positive, 15% cirrhotic. 99% know 
alcohol can damage the liver and 86% answered that any alcohol quantity is poten-
tially harmful (79% do not assume alcohol and 62% go on after being cured). Besides 
alcohol, other foods believed to be harmful to liver are all fried foods, salami, sugar 
and sweets, meat (in particular red meat), cheeses (above all fat cheeses). Although 
in low percentages, 5% and 13% respectively consider vegetables and fruit as harm-
ful. Moreover, 53% think a vegan/vegetarian diet is essential, but 81% would like to 
have a specialist nutritional advice. ConClusions: Considering that nutritional 
aspects are important in everybody’s life, they are particularly relevant in case of 
liver disease. The results shown express patients’ degree of knowledge about these 
aspects and highlights that a certain disinformation is widespread. The results 
also point out liver-suffering patients’ need to receive clinicians’ evidence-based 
advice/information on nutrition and lifestyle as part of the routine counselling 
and to develop an educational campaign on nutrition for hepatopathic patients.
severity*10%risk”:0.355; coef.“moderate severity *10% risk”:0.112; coef.“severe sever-
ity *10% risk”:-0.246; coef.“mild severity *40% risk”: 0.165; coef.”moderate severity 
*40% risk”:-0.116; coef.“severe severity *40% risk”: -0.271. ConClusions: The DCE 
could prove that the included hepatitis C patients have different preferences with 
respect to the probability of risk relative to the severity of different side-effects. In 
all significant characteristics the dominance for less severity and less risk could be 
proven and both aspects were taken into account when making treatment decisions. 
For the first time compound side-effect attributes have been applied in a preference 
elicitation method and detected corresponding differences within patient prefer-
ence measures.
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objeCtives: Ulcerative colitis (UC) management aims to reduce symptoms 
associated with the disorder as well as inducing and maintaining remission. 
Surgery is typically considered in severe or refractory UC patients who have not 
responded to maximal treatment. This study evaluated HRQL following surgery, 
along with experience and severity of complications, including those experienced 
in the longer-term. Methods: UK adult UC patients (n= 202) who had undergone 
bowel surgery completed an online survey including EQ-5D-5L utility assessment, 
Work Productivity and Activity Impairment (WPAI), Inflammatory Bowel Disease 
Questionnaire (IBDQ), post-surgical complications, and Female Sexual Function 
Index (FSFI) or International Index of Erectile Function (IIEF). Results: Over 58% 
of participants were > 1 year post-surgery. Mean EQ-5D utility for the overall sample 
was 0.74. Mean utility was significantly higher in those who reported no complica-
tions post-surgery than in those who did (0.90 vs 0.71; p< 0.001). The most commonly 
reported symptoms since surgery were increased fatigue (56%), abdominal pain 
(42%), and increased stool frequency (31%). Participants with complications had 
reduced HRQL across bowel symptoms, systemic symptoms, emotional functioning 
and social functioning IBDQ domains. They also reported more work time missed, 
greater impairment while working and greater overall impairment of regular activi-
ties due to UC than those without complications. Of those responding about sexual 
function, FSFI scores for 68% of female participants indicated sexual dysfunction 
and IIEF scores for 52% of male participants indicated at least mild erectile dysfunc-
tion. A marked decrease in utility by IBDQ disease severity was observed: those 
classified as having severe disease had lower scores than those classified as being 
in remission (0.52 vs 0.88). ConClusions: Although surgery for UC is intended 
to be curative, IBDQ and EQ-5D data suggest that HRQL may not return to normal 
levels. These results may be related to severity of ongoing fatigue, bowel and sexual 
function problems.
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objeCtives: Short bowel syndrome (SBS) is a rare, complex clinical condition that 
results from loss of intestinal absorptive capacity. Parenteral nutrition (PN) is often 
needed to maintain clinical status in patients with SBS. Teduglutide reduces, and 
in some cases eliminates, patients’ dependency on PN. PN is not exclusively used 
in patients with SBS and, since robust utility data is often difficult to collect for rare 
conditions due to limited patient numbers, a wider body of published literature 
reporting a link between PN and health-related quality of life (HRQL) was consid-
ered. We assessed if an acceptable body of evidence was available to determine the 
HRQL impact associated with the use of PN that could support an assessment of 
the potential impact of reduced PN using teduglutide. Methods: Searches were 
performed using MEDLINE, MEDLINE In-Process and Cochrane Library. Additionally, 
hand searches were performed at targeted conferences. Of 2,724 studies screened, 
76 met the inclusion criteria: adults receiving PN for longer than 6 months and 
reported utilities or other HRQL data. Results: Patients receiving PN were shown 
to have lower HRQL than the general population. HRQL was shown to increase 
at initiation of PN, compared to the pre-PN state. However, discontinuation of PN 
and intestinal transplantation (ITx) were associated with further improvements in 
HRQL. Trends associating increased number of PN complications, PN volume and 
PN frequency with lower HRQL were also identified. ConClusions: Improvements 
in HRQL achieved by discontinuing PN and ITx suggest that weaning patients with 
SBS off PN could increase HRQL. These, along with results of an ongoing vignette 
study in patients with SBS, may allow quantification of the HRQL associated with 
the use of teduglutide in SBS.
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objeCtives: Following the 2009 FDA Guidance, a new PRO instrument was devel-
oped to support endpoints in multinational clinical trials assessing IBS with diar-
rhea (IBS-D) symptom severity. Our objective was to assess the translatability of 
the IBS-D PRO instrument into ten languages, and subsequently perform a cultural 
adaptation/linguistic validation of the questionnaire into US Spanish and Japanese.] 
